A Multicenter, Multinational, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra; When Used In Routine Medical Practice (LIBERATE)

Trial Profile

A Multicenter, Multinational, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra; When Used In Routine Medical Practice (LIBERATE)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Fampridine (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Acronyms LIBERATE
  • Sponsors Biogen
  • Most Recent Events

    • 05 Apr 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2020 as reported by ClinicalTrials.gov record.
    • 10 May 2012 Additional trial location (Norway) added as reported by ClinicalTrials.gov.
    • 10 May 2012 Actual initiation adet 1 Apr 2012 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top